|Molar Mass||1182.311 g·mol−1|
Gonadorelin Vials are a specialized research-grade product crafted for scientific exploration and experimentation. Strictly designated for research purposes, these vials contain Gonadorelin, a synthetic form of gonadotropin-releasing hormone (GnRH), recognized for its potential therapeutic applications.
Gonadorelin Vials are characterized by the inclusion of highly purified Gonadorelin, ensuring the precision and reliability of research findings. Formulated for enduring stability under appropriate storage conditions, these vials maintain their integrity over time. Each vial is precisely dosed, facilitating consistent and accurate research outcomes.
Gonadorelin Vials find application in diverse research areas, with a primary focus on unraveling the molecular mechanisms and potential therapeutic benefits associated with GnRH analogs.
Gonadorelin and Breast Cancer
Exploratory studies suggest a potential link between Gonadorelin and breast cancer. Research in this area investigates the hormone’s impact on breast cancer cells, aiming to provide insights into novel therapeutic approaches or preventive strategies.
Gonadorelin and Male Infertility
Gonadorelin’s role in addressing male infertility is a subject of research interest. Studies indicate its potential to stimulate the production of reproductive hormones, offering possibilities for understanding and addressing male reproductive challenges.
Gonadorelin and Dementia
Research examining the relationship between Gonadorelin and dementia explores the hormone’s neuroprotective effects. Preliminary studies suggest a potential connection, prompting further investigations into the therapeutic implications for cognitive function and neurodegenerative disorders.
In summary, Gonadorelin Vials serve as a valuable tool for researchers delving into the multifaceted benefits of Gonadorelin. From exploring its potential impact on breast cancer cells to investigating its role in addressing male infertility and potential connections to dementia, these vials offer a platform for advancing knowledge in critical research areas. It is imperative to emphasize that this product is exclusively intended for research purposes and is not intended for human consumption.
- Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V. A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women. Breast Cancer Res Treat. 2016 Aug;158(3):553-61. doi: 10.1007/s10549-016-3901-1. Epub 2016 Jul 9. PMID: 27393623. [Read More]
- Rajkanna J, Tariq S, Oyibo SO. Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism. Endocrinol Diabetes Metab Case Rep. 2016;2016:150124. doi: 10.1530/EDM-15-0124. Epub 2016 Jan 7. PMID: 26807263; PMCID: PMC4722247. [Read More]
- Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer’s disease. Endocrine. 2005 Apr;26(3):317-26. doi: 10.1385/ENDO:26:3:317. PMID: 16034187. [Read More]